Carl Erik Mogensen
Overview
Explore the profile of Carl Erik Mogensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
3862
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porrini E, Ruggenenti P, Mogensen C, Pongrac Barlovic D, Praga M, Cruzado J, et al.
Lancet Diabetes Endocrinol
. 2015 May;
3(5):382-91.
PMID: 25943757
Largely on the basis of data from patients with type 1 diabetes, the natural history of diabetic renal disease has been classified as a sequence of three stages: normoalbuminuria, microalbuminuria,...
2.
Schernthaner G, Mogensen C, Schernthaner G
Diab Vasc Dis Res
. 2014 Aug;
11(5):306-23.
PMID: 25116004
Diabetic nephropathy (DN) affects an estimated 20%-40% of patients with type 2 diabetes mellitus (T2DM). Key modifiable risk factors for DN are albuminuria, anaemia, dyslipidaemia, hyperglycaemia and hypertension, together with...
3.
Mogensen C
J Diabetes Investig
. 2014 May;
1(3):97-100.
PMID: 24843414
A number of controversies in diabetes have had too little attention. I discuss the following issues: (i) drug therapy; (ii) genetics; (iii) antihypertensive treatment in patients with normoalbuminuria and with...
4.
de Vries A, Ruggenenti P, Ruan X, Praga M, Cruzado J, Bajema I, et al.
Lancet Diabetes Endocrinol
. 2014 May;
2(5):417-26.
PMID: 24795255
The global increase in chronic kidney disease (CKD) parallels the obesity epidemic. Obesity conveys a gradual but independent risk of progression of CKD that seems irrespective of the underlying nephropathy....
5.
Perkovic V, Heerspink H, Chalmers J, Woodward M, Jun M, Li Q, et al.
Kidney Int
. 2013 Jan;
83(3):517-23.
PMID: 23302714
The effect of intensive glucose control on major kidney outcomes in type 2 diabetes remains unclear. To study this, the ADVANCE trial randomly assigned 11,140 participants to an intensive glucose-lowering...
6.
Olivarius N, Siersma V, Nielsen A, Hansen L, Rosenvinge L, Mogensen C
BMC Endocr Disord
. 2010 Aug;
10:14.
PMID: 20698977
Background: At diabetes diagnosis major decisions about life-style changes and treatments are made based on characteristics measured shortly after diagnosis. The predictive value for mortality of these early characteristics is...
7.
Knudsen S, Jeppesen P, Frederiksen C, Andersen N, Bek T, Ingerslev J, et al.
J Am Soc Hypertens
. 2010 Apr;
1(3):208-15.
PMID: 20409852
Reduced diurnal blood pressure (BP) variation ("non-dipping") is associated with both micro- and macrovascular complications in patients with type 2 diabetes. The relation between endothelial perturbation and diurnal BP variation...
8.
Olsen M, Ibsen H, Mogensen C
Ugeskr Laeger
. 2009 Aug;
171(25):2097-100.
PMID: 19671389
Microalbuminuria is common in patients with hypertension and even lower levels of albuminuria reflect subclinical cardiovascular damage which is associated with increased cardiovascular risk. Reduction of albuminuria is associated with...
9.
Mikkelsen M, Andersen N, Christensen T, Hansen T, Eiskjaer H, Mogensen C, et al.
Interact Cardiovasc Thorac Surg
. 2009 Jun;
9(3):484-90.
PMID: 19549646
Objectives: To examine if preoperative microalbuminuria (MA) is associated with in increased risk of adverse outcomes in patients undergoing elective cardiothoracic surgery, and if adding information on MA could improve...
10.
Ryden L, Waeber B, Ruilope L, Mancia G, Volpe M, Holzgreve H, et al.
Blood Press
. 2008 Nov;
17(5-6):250-9.
PMID: 19012063
Patients with comorbid hypertension and type 2 diabetes are common, have a greatly increased risk of premature cardiovascular and renal morbidity and mortality, and are likely to increase substantially in...